Specific characteristics of scirrhous hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 56, Issue 93, 2009, Pages 1086-1089

  Sugiki, Takaaki ^a   Yamamoto, Masakazu ^a   Taka, Ken ^a   Nakano, Masayuki ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION CHIBA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; HEPATITIS C ANTIBODY; HEPATOCYTE PARAFFIN 1; MUCIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LIVER CELL; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCIRRHOUS HEPATOCELLULAR CARCINOMA; ADENOCARCINOMA; CHI SQUARE DISTRIBUTION; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA, SCIRRHOUS; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 70350498825     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ishak K, Anthony P, Sobin L: Histological typing of tumours of the liver. 2nd ed. WHO. New York: Springer-Verlag, 1994 (WHO International Histological Classification of Tumours).
2. Liver Cancer Study Group of Japan: General rules for the clinical and pathological study of primary liver cancer. Second English Edition, Tokyo: Kanehara Press Co., 2003.
3. Omata M, Peters RL, Tatter D: Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver 1981; 1:33-49. (Pubitemid 11015251)
4. Iha H: Clinicopathological study on scirrhous hepatocellular carcinoma -A study of 12 resected cases. Acta Hepatologica Japonica 1994; 35:855-863.
5. Wennerberg AE, Nalesnik MA, Coleman WB: Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am J Pathol 1993; 143:1050-1054. (Pubitemid 24070547)
6. Yamashita F, Iwao T, Torimura T: Sclerosing hepatocellular carcinoma with hypercalcemia. A Case Report. Kurume Med J 1992; 39:113-116.
7. Leong AS, Sormunen RT, Tsui WM, et al.: Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumors and metastatic carcinoma. Histopathology 1998; 33:318-324. (Pubitemid 28508880)
8. Minevini MI, Demetris AJ, Lee RG, et al.: Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of Liver tumors. Mod Pathol 1997; 10:686-692. (Pubitemid 27321760)
9. Siddiqui MT, Saboorian MH, Gokaslan ST, et al.: Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer (Cancer Cytopathol) 2002; 96:49-52. (Pubitemid 34194320)
10. Liver Cancer Study Group of Japan: Survey and follow-up study of primary liver cancer in Japan. Report 15. Kyoto: Liver Cancer Study Group of Japan, 2002.
11. Peiguo GC, Ishizawa S, Emerald W, et al.: Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistological comparison to carcinoembryonic antigen, CD10, and alpha-fetoproteon. Am J Surg Pathol 2002; 26(8):978-988. (Pubitemid 34810558)
12. Yamamoto M, Ariizumi S, Yoshitoshi K, et al.: Hepatocellular Carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance. J. Surg. Oncol. 2006; 94(7):587-591. (Pubitemid 44851919)
13. Sugiki T, Yamamoto M, Aruga A, et al.: Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1. J. Surg. Oncol. 2004; 88(2):104-107. (Pubitemid 39536511)
14. Kumagai I, Masuda T, Sato S, et al.: Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern. Hepatology Research 2001; 20:312-319. (Pubitemid 32573893)
15. Matsuura S, Aishima S, Taguchi K, et al.: Scirrhous type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1. Histopathology. 2005; 47:382-390. (Pubitemid 41428487)